Medicine
Tezspire 211.105 mg/1.91 mL injection
Tezspire 211.105 mg/1.91 mL injection is a prescription medicine containing Tezepelumab for subcutaneous use, marketed by Amgen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated between 36°F to 46°F (2°C to 8°C). Do not put back in the…
Key facts
- Active ingredient (INN)
- Tezepelumab
- Brand
- Tezspire
- Strength
- 211.105 mg/1.91 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 1.91 mL, 1 cartridge of 1.91 mL
- Marketing authorisation holder
- Amgen
- Manufacturer
- Amgen
- Origin register
- US FDA, United States
- Storage
- Store refrigerated between 36°F to 46°F (2°C to 8°C). Do not put back in the refrigerator once TEZSPIRE has reached room temperature. After removal from the refrigerator, TEZSPIRE must be used within 30 days or discarded. Do not freeze. If necessary, TEZSPIRE may be kept at room temperature between 68°F to 77˚F (20°C to 25°C) for a maximum of 30 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03DX11 Tezepelumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 December 2021
- Identifiers
- RxCUI 2587794, 2587800, 2587803 +3DailyMed set ID 60f0aa03-ad25-4d48-80ce-7fcfa76f325fNDC 55513-123, 55513-112Application BLA761224
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Tezepelumab is a thymic stromal lymphopoietin blocker indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, among other approved uses. MedsAcross supplies Tezepelumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TezepelumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TEZSPIRE prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Tezspire: European public assessment report (EPAR) · European Medicines Agency
Need Tezspire 211.105 mg/1.91 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.